5N Plus (VNP) Q4 2024 earnings summary

Executive summary

• Annual revenue grew 19% to $289.3 million in FY 2024, with record Adjusted EBITDA up 39% to $53.3 million, driven by strong demand in Specialty Semiconductors and Performance Materials.

• Q4 2024 revenue rose 9% year-over-year to $70.9 million, led by Specialty Semiconductors, especially in renewable energy and space solar sectors.

• Net earnings for FY 2024 were $14.7 million, slightly down from $15.4 million in FY 2023, despite higher operating performance.

• Backlog at year-end was $252.8 million, representing 326 days of annualized revenue, up 34 days year-over-year.

• Strategic focus on high-margin, value-added materials and operational agility underpinned results.

Financial highlights

• Adjusted gross margin for FY 2024 was $91.3 million (31.6% of sales), up from $70.2 million (29.0%) in FY 2023.

• Q4 2024 Adjusted EBITDA increased 38% to $12.5 million; full-year Adjusted EBITDA was $53.3 million, up 39% year-over-year.

• Net debt at year-end was $100.1 million, up from $73.8 million, with net debt to EBITDA ratio at 2.02x.

• Working capital at year-end was $156.9 million, with a current ratio of 3.59, up from 2.22 a year earlier.

• Basic EPS for FY 2024 was $0.17, unchanged from FY 2023.

Outlook and guidance

• FY 2025 Adjusted EBITDA guidance raised to $55–$60 million, up from prior $50–$55 million, driven by Specialty Semiconductors demand.

• Guidance based on existing contracts and anticipated demand, especially in renewable energy, space solar, and medical imaging sectors.

• Performance Materials growth expected from health and pharmaceutical sectors, with bismuth chemicals demand tracking GDP.

• External growth opportunities actively pursued; operational flexibility supports organic growth.

• 2026 guidance deferred due to global economic and U.S. political/trade uncertainties.